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Among the three embryonic germ layers, the meso-
derm is a major source of the mesenchymal precur-
sors giving rise to skeletal and connective tissues,
but these precursors have not previously been
identified and characterized. Using human embry-
onic stem cells directed toward mesendodermal
differentiation, we show that mesenchymal stem/
stromal cells (MSCs) originate from a population of
mesodermal cells identified by expression of apelin
receptor. In semisolid medium, these precursors
form FGF2-dependent compact spheroid colonies
containing mesenchymal cells with a transcriptional
profile representative of mesoderm-derived embry-
onic mesenchyme. When transferred to adherent
cultures, individual colonies give rise to MSC lines
with chondro-, osteo-, and adipogenic differentiation
potentials. Although the MSC lines lacked endothe-
lial potential, endothelial cells could be derived
from the mesenchymal colonies, suggesting that,
similar to hematopoietic cells, MSCs arise from
precursors with angiogenic potential. Together,
these studies identified a common precursor of
mesenchymal and endothelial cells, mesenchy-
moangioblast, as the source of mesoderm-derived
MSCs.
INTRODUCTION
Mesenchymal stem/stromal cells (MSCs) are fibroblastoid cells
capable of long-term in vitro expansion and multilineage
differentiation to bone, cartilage, adipose, and connective
tissues (Bianco et al., 2008; Dennis and Charbord, 2002;
Friedenstein et al., 1974; Prockop, 1997). In addition, MSCs
give rise to hematopoiesis-supportive stroma and contribute to
the formation of the hematopoietic stem cell (HSC) niche (Blaz-
sek et al., 2000; Delorme et al., 2006; Muguruma et al., 2006)
and vascular wall (Crisan et al., 2008). AlthoughMSCs are widely
used for cellular therapies and tissue engineering, their precur-
sors remain largely unknown. Thus, there is a need to define
developmentally distinct MSC subsets and the hierarchy of their718 Cell Stem Cell 7, 718–729, December 3, 2010 ª2010 Elsevier Incprogenitors to advance our understanding of heterogeneity
within MSCs and its implications for the developmental and ther-
apeutic potential of these cells.
Studies in mouse embryo demonstrated the origin of MSCs
from neural crest (Morikawa et al., 2009; Trentin et al., 2004). In
addition, Sox1+ neuroepithelial cells were identified as progeni-
tors that give rise to MSCs through a neural crest intermediate
stage (Takashima et al., 2007). Recently, the MSC potential of
neural crest stem cells generated from human embryonic stem
cells (hESCs) was shown (Lee et al., 2007). The mesoderm is
considered to be another and major source of mesenchymal
cells giving rise to skeletal and connective tissues (Dennis and
Charbord, 2002). An early Flk1+ mesodermal precursor, with
the potential to differentiate into endothelial cells, blood, muscle,
and mesenchymal lineage cells (bone and cartilage), was identi-
fied in the E9.5 mouse dorsal aorta (Minasi et al., 2002). Evalua-
tion of osteogenic, chondrogenic, and adipogenic potential of
cells isolated from different anatomical sites in the E11 mouse
embryos revealed itraembryonic hematopoietic tissues (aorta-
gonad-mesonephros) as a site of origin for cells with mesen-
chymal differentiation potential (Mendes et al., 2005). However,
immediate mesodermal precursors that give rise to expandable
multipotential MSC lines are not identified and characterized.
To identify MSC precursors of mesodermal origin, we em-
ployed an hESC differentiation system that reproduces many
aspects of early embryonic development and provides access
to cells otherwise inaccessible in humans that represent the
earliest stages of mesodermal commitment (Gadue et al.,
2005; Kennedy et al., 2007; Kennedy et al., 1997; Yang et al.,
2008; Zambidis et al., 2005). Althoughmultiple studies described
successful generation of MSCs from hESCs and induced plurip-
otent stem cells (iPSCs), including demonstration of fibroblast-
colony forming activity (Barberi et al., 2005; Boyd et al., 2009;
Karlsson et al., 2009; Lee et al., 2007; Lian et al., 2007; Lian
et al., 2010; Olivier et al., 2006; Trivedi and Hematti, 2008), origin
of MSCs in these cultures remains obscure. Mesenchymal
‘‘precursors’’ identified in these studies were isolated using
typical MSC markers such as CD73 or CD105 and were defined
as cells with osteo-, chondro-, and adipogenic potential
(i.e., representing de factoMSCs rather than cells predetermined
to MSC fate or true MSC precursors). Here, using hESCs
directed to mesendodermal differentiation through coculture
with OP9, we show that mesoderm-derived MSCs arise from
a common endothelial and mesenchymal cell precursor, mesen-
chymoangioblast, a transient population of cells within APLNR+.
Figure 1. Identification of Mesenchymal
Colony-Forming Cells
(A) Development of MS and BL colonies in semi-
solid culture. Scale bar represents 100 mm.
(B) Kinetics of MS-, BL-, and Hem- (hematopoi-
etic) CFCs in H1 hESC/OP9 coculture. Error bars
represent standard deviation of six independent
experiments.
(C) The effect of adding cytokines to clonogenic
cultures on MS and BL colony formation. ActA
denotes activin A. Error bars represent standard
deviation of four independent experiments.
*p < 0.01. See also Figures S1 and S2.
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Identification of Mesenchymoangioblastmesodermal subset that can be identified using FGF2-depen-
dent mesenchymal colony-forming cell (MS-CFC) assay in
serum-free semisolid suspension culture.
RESULTS
Identification of Mesenchymal Colony-Forming Cells
in hESCs Differentiated in Coculture with OP9
To identify human mesenchymal precursors of mesodermal
origin, we employed hESC coculture with OP9, which is known
as an efficient differentiation system for cells of mesodermal line-
ages, including hematopoietic, vascular, and cardiac cells
(Nakano et al., 1994; Schroeder et al., 2003; Vodyanik et al.,
2005). Molecular profiling of OP9-depleted hESC-derived cells
differentiated throughout days 1–7 demonstrated selective
commitment toward mesodermal and endodermal lineages
with no detectable ectoderm (tropho-, neuro-, or surface ecto-
derm; see Figure S1 available online). Kinetically, the T, MIXL1,
and EOMES transcription factors involved in induction of mesen-
doderm were upregulated synchronously and peaked on day 2
of differentiation. This was followed by expression of mesoderm-
and endoderm-specific genes and coincided with a maximal cell
proliferation on day 3 of differentiation. This stage was also
accompanied by sustained expression of SNAI1 and SNAI2
genes involved in epithelial-mesenchymal transition. Among
the mesodermal subsets, only genes representing lateral plate/
extraembryonic mesoderm (FOXF1,HAND1,GATA2) were upre-
gulated, whereas no substantial expression of axial (CHRD,
SHH), paraxial/myogenic (MEOX1, TCF15, MYOD1, MYF5,
PAX3, PAX7), or intermediate (PAX2, PAX8, OSR1) mesoderm
genes was noticed. Following 4–5 days of differentiation, speci-
fication of endodermal and mesodermal lineages was observed.
Because fibroblast growth factor (FGF) signaling is involved in
specification, migration, and patterning of mesoderm during
embryonic development (Ciruna and Rossant, 2001) and MSCCell Stem Cell 7, 718–729,expansion (Tsutsumi et al., 2001) and
because of our observation that FGF2
selectively increased the mesenchymal
subpopulation of hESC-derived CD34+
cells (Figure S2), we tested whether any
hESC-derived cells with colony-forming
mesenchymal potential could be de-
tected in FGF2-supplemented semisolid
media. In accordance with upregulation
of genes marking mesodermal commit-ment on days 2–3 of hESC differentiation in coculture, we
observed FGF2-dependent colony-forming activity when
hESC-derived cells were plated in serum-free semisolid
medium. Day 2 cells generated compact, sharply circumscribed
spheroid colonies formed by tightly packed cells, whereas day 3
cells mostly produced disperse colonies with a morphology
similar to the previously described blast (BL) or hemangioblast
colonies (Figure 1A), which are known derivatives of angiohema-
topoieticmesoderm (Choi et al., 1998; Kennedy et al., 2007; Ken-
nedy et al., 1997). Both colony types were generated at relatively
high frequency, comprising up to 2%–3% of the total hESC-
derived cells (Figure 1B). Similar to BL colonies (D’Souza et al.,
2005), compact colonies were formed through establishment
of tightly packed single-cell-derived structures (cores), which
expand into spheroid colonies (Figure 1A and Movies S1–S3).
Both compact and BL colony formation were solely dependent
on the presence of FGF2, but not other tested factors (VEGF,
SCF, IGF1, EGF, and HGF; Figure 1C and data not shown),
and required serum-free medium. Although previous studies re-
ported the VEGF dependence of BL colonies generated using
embryoid body method (Kennedy et al., 2007; Kennedy et al.,
1997), we could not detect any colonies when VEGF used alone
and its addition to FGF2 had no significant effect on the number
of BL colonies from hESCs differentiated on OP9. It is possible
that this discrepancy could be attributed to the differences in
differentiation systems, for example, a high level of autocrine
VEGF production by hESCs differentiated on OP9 or the pres-
ence of inhibitors and/or modulators of VEGF signaling in
embryoid body system. The formation of compact and BL colo-
nies was completely abrogated by adding transforming growth
factor b1 or activin A (1 ng/ml) to clonogenic cultures (Figure 1C)
or in presence of serum. Although PDGF-BB alone lacked
colony-forming activity, its addition to FGF2 significantly
increased the frequency and size of compact colonies.
In contrast, the addition of VEGF to FGF2 cultures essentiallyDecember 3, 2010 ª2010 Elsevier Inc. 719
Figure 2. Characterization of Mesenchymal
Colonies and Cell Lines Derived from Them
(A) Derivation of MSC line from individual MS
colony. Panels show morphology of MS colony in
semisolid media and after placement on fibro-
nectin- and collagen-coated dishes, as well as
MCS line after 1st (p1) and 5th (p5) passage. Scale
bars represent 200 mm.
(B) Flow cytometric analysis of MS colonies and
polyclonal and 24 individual clonal MSC lines. p4
denotes passage 4; EMCN denotes endomucin.
(C) Summary of phenotype of MS colonies and
MSC lines at passage 5 (p5), as detected by flow
cytometry. Error bars represent standard devia-
tion of three independent experiments.
(D) Divergent gene expression profile of MS and
BL colonies. Selected transcripts defining meso-
dermal, mesenchymal, and hematopoietic line-
ages are shown.
(E) Quantitative RT-PCR analysis of gene expres-
sion in individual MS colonies. Each dot on the
graphs represents gene expression level in a single
colony. Horizontal lines show average expression
levels for all tested colonies (n = 30).
(F) Expansion potential of polyclonal cell lines
(mean doubling time [dT] and standard deviation
for four lines are shown).
(G) Expansion potential of ten individual clonal cell
lines derived from a single MS colony. See also
Figures S3 and S6.
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Identification of Mesenchymoangioblastabrogated formation of compact colonies at the core stage
(Figure 1C). It is important to notice that both types of colonies
represent a transient population of cells that could not be de-
tected beyond 4 days of differentiation when the first hematopoi-
etic colonies arise (Figure 1B).
Phenotypic analysis of fully developed spheroid colonies (day
12 of clonogenic culture) demonstrated that they consist of
a uniform population of CD140a+CD90+CD56+CD166+CD31
CD43CD45 cells, with the majority of cells expressing MSC
and perivascular cell marker CD146 (Crisan et al., 2008; Sac-
chetti et al., 2007), indicating the mesenchymal identity of these
colonies (Figures 2B and 2C). Thus, we designated these colo-
nies as mesenchymal (MS) colonies, and we designated cells
forming these colonies as MS-CFCs. It is noteworthy that cells
within colonies expressed endomucin, endothelial tyrosine
kinase (TEK or TIE2), and VEGFR1 (FLT1, Figures 2B and 2C),
molecules typically associated with endothelial cells. Transcrip-
tional profiling of MS and BL colonies clearly demonstrated that720 Cell Stem Cell 7, 718–729, December 3, 2010 ª2010 Elsevier Inc.MS colonies were enriched in genes
representative of embryonic mesen-
chyme originating from lateral plate/
extraembryonic mesoderm (FOXF1,
HAND1, NKX2-5, SNAI2, CDH11,
RUNX2, SOX9), whereas BL colonies
were enriched in genes signifying hema-
topoietic commitment (GATA1, NFE2,
TAL1, SPI1, VAV1; Figure 2D). Reverse
transcriptase-polymerase chain reaction
(RT-PCR) analysis of individual MS colo-
nies revealed that essentially all colonieslacked expression of ESC (POU5F1, SOX2), neuroectoderm
(SOX2), mesendoderm (T), and endoderm (FOXA2)-specific
genes but showed a high expression of lateral plate/extraembry-
onic mesoderm-specific marker FOXF1 and genes essential for
epithelial-mesenchymal transition (SNAI2) and bone and carti-
lage development (RUNX2, SOX9). However, expression of
genes involved in adipogenesis (PPARG) and myogenesis
(MYF5) was not detected (Figure 2E).
Similar to hESCs, MS-CFCs were also generated from iPSCs,
although we noted that MS colonies with typical morphology
couldbeobtained only from transgene-free iPSCs. Lentivirally re-
programmedcells generated colonieswith aberrantmorphology,
indicating that background expression of transgenes could affect
the spatial organization of colonies (Figure S3A).
Single-Cell Origin of Mesenchymal Colonies
As observed by time-lapse photography, MS colonies devel-
oped from single cells (Movie S1). To confirm single-cell origin
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Figure 3. Demonstration of Single-Cell Origin of
Mesenchymal Colonies
(A) H1 cells expressing either EGFP or mOrange-H2BB fusion
protein were used for preparation of chimeric H1 cell line
containing equal proportions of randomly mixed EGFP- and
mOrange-positive cells. Graph indicates the numbers of single
color (red or green) or mixed (black) colonies in semisolid
clonogenic culture at different plating densities. Scale bars
show the absolute numbers of single color (red or green) or
mixed (black) colonies in semisolid clonogenic culture counted
at different plating densities. Numbers above bars indicate
percentage of mixed colonies of total colonies counted.
(B) A single-cell deposition of APLNR+ HES2.R26tdRFP cells
into methylcellulose medium with feeder culture of colony-
forming H1 hESCs (104 cells/ml).
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Identification of Mesenchymoangioblastusing alternative assays, we prepared a chimeric hESC (H1) line
containing equal proportions of randomly mixed EGFP- and
mOrange-marked H1 hESCs and assayed it for MS-CFCs. By
prediction, if colonies are derived from single cells, no mixed
colonies should be observed. However, if at least two or more
cells are required, half or more of the colonies should be mixed.
When the MS-CFC assay was performed with a differentiated
chimeric cell population, almost all of the MS colonies were
single colored, either EGFP or mOrange positive. A minority of
mixed colonies (<5%) was observed only in cultures with high
cell-plating density. At the density of 104 cells/ml, all counted
colonies (n = 189) were of a single color (Figure 3A), thus demon-
strating that MS colonies arise from single cells, but not from cell
aggregates. As additional proof of clonality, we performed
a single-cell deposition assay that revealed that singly deposited
cells generated MS colonies with a frequency similar to bulk
cultures (1%; Figure 3B).
Mesenchymal Colonies Originate from Precursors
with Endothelial Potential
To elucidate the differentiation potential, we collected MS colo-
nies and transferred them back onto OP9 for an additional four
days of culture. As shown in Figure 4A, the majority of cells
differentiated from compact colonies expressed CD146+
CD31CD43CD45 MSC phenotype (Sacchetti et al., 2007).
However, we also noticed a readily identifiable population ofCell Stem Cell 7,CD31+/CD144+CD43 endothelial cells compris-
ing up to 7% of the total hESC-derived cells.
When MS colonies were plated on Matrigel matrix,
endothelial cells migrated out of colonies and
organized into a network of typical vascular
tubes (Figure 4C). The endothelial potential of
MS colonies could be significantly enhanced
with the addition of bone morphogenic protein 4
to colony-forming medium (BMP4; Figure 4D).
Despite readily detectable endothelial differentia-
tion, CD43+ (Vodyanik et al., 2006) or CD45+
hematopoietic cells were never detected in these
cultures, even from colonies generated in pres-
ence of BMP4 (Figures 4A and 4D and Figure S4A).
When individual compact spheroid colonies were
transferred onto OP9, about 70% of the colonies
generated CD144 (VE-cadherin)+ endothelial cellsin addition to the mesenchymal cells identified by expression
of calponin (Figure 4B). By contrast, BL colonies generated
predominantly CD43+ hematopoietic cells with some CD31+/
CD144+CD43 endothelial cells and CD146+CD31 mesen-
chymal cells (Figures 4A and 4B). Kinetic analysis of the angio-
genic potential of MS colonies at different stages of maturation
revealed that the formation of mesenchymoendothelial clusters
was the most prominent from colonies collected on day 6 of
clonogenic culture. Three-day-old (core stage) and 12-day-old
(mature stage) colonies formed predominantly endothelial and
mesenchymal clusters, respectively (Figures S4B and S4C).
Based on specific morphology, differentiation potential, and
contrasting VEGF response, we concluded that the compact
spheroid colonies represent common precursor for mesen-
chymal and endothelial lineages distinct from the already-
described BL-CFC (Choi et al., 1998; Kennedy et al., 2007;
Kennedy et al., 1997). By analogy with hemangioblast, we
designated this novel mesenchymal and endothelial precursor
as mesenchymoangioblast.
Single Mesenchymal Colonies Give Rise to MSC Lines
When individual MS colonies were plated on the collagen- and
fibronectin-coated plastic, immediate attachment and vigorous
outgrowth of fibroblast-like cells were observed (Figure 2A).
Following expansion, cells grew intensively during the first
10 passages (doubling time [dT ] = 18–23 hr), growth rate was718–729, December 3, 2010 ª2010 Elsevier Inc. 721
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Figure 4. Demonstration of Endothelial Potential of Mesenchymal Colonies
(A) Differentiation potential of MS and BL colonies collected on day 12 of clonogenic culture after replating on OP9. Flow cytometric analysis demonstrates devel-
opment of CD146+CD31 mesenchymal, CD31+CD146+CD43 endothelial, and CD43+ hematopoietic lineages.
(B) Immunostaining analysis of cell clusters developed from a single MS (top, scale bar, 100 mm) and BL (bottom, scale bar, 50 mm) colony collected on day 5 of
clonogenic culture. Cells are identified as CD144(VE-cadherin)+CD43 endothelial, CD43+ hematopoietic, and calponin+ CD144 mesenchymal.
(C) Vascular tube formation by MS colonies collected on day 6 of clonogenic culture. Scale bar represents 20 mm.
(D) Effect of the addition of BMP4 to clonogenic media on endothelial potential of individual colonies on OP9. Left upper quadrant numbers show percentage of
CD31+ endothelial cells (mean ± standard deviation [SD] of six independent experiments).
(E) Lack of endothelial potential of MSC lines after coculture with OP9. Note that MSCs acquire expression of CD34 after coculture with OP9, but CD31+ endo-
thelial cells are not observed. See also Figure S4.
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Identification of Mesenchymoangioblastattenuated at 10–15 passages (dT = 30–35 hr), and gradual
senescence was observed during 15–25 passages (Figure 2F).
Cultures derived from single MS-CFC accumulated up to 1022
total cells (Figure 2G). Assuming a single-cell origin of
colonies, this number corresponds to the expansion potential
of a single hESC-derived mesenchymal precursor. Although
the cells composing the MS colonies were lacking CD73 and
expressed CD105 weakly, colony-derived cell lines up-
regulated their expression, displayed CD146+CD73+CD105+
CD31CD43CD45 phenotype, typical of adult bone marrow
MSCs, and maintained normal karyotype (Figures 2B and 2C;722 Cell Stem Cell 7, 718–729, December 3, 2010 ª2010 Elsevier IncFigure S3B). Generated MSC lines could be differentiated in
the chondro-, osteo-, and adipogenic conditions, with triple
potential detected in the majority of single colony-derived lines
(Figure 5). This finding provides functional confirmation of the
MSC nature of the colony-derived cell lines and proves MSC
origin from mesenchymoangioblasts. Neither endothelial nor
hematopoietic cells could be detected after coculture of MSC
lines with OP9 cells (Figure 4E). The same was true in the
feeder-free culture with hematoendothelial growth factors
(VEGF, FGF2, SCF, TPO, IL3, IL6; data not shown), indicating
the restricted differentiation potential of expanded MSCs..
Figure 5. Skeletogenic Differentiation
Potential of MSC Lines
(A–F) Chondrogenesis is shown in (A) by Alcian
blue staining and in (B) by glycosaminoglycan
(GAG) production following differentiation in chon-
drogenic conditions. Osteogenesis is shown in (C)
by Alizarin red staining and in (D) by calcium accu-
mulation following differentiation in osteogenic
conditions. Adipogensis is shown in (E) by Nile
red staining and in (F) by fat accumulation
following differentiation in adipogenic conditions.
In (A), (C), and (E), scale bars represent 100 mm.
In (B), (D), and (F), error bars represent SD of
mean obtained at indicated time points (days
0–36 of differentiation) using polyclonal cell lines
(n = 3). *p < 0.01 as compared to day 0. Each
dot on the graphs represents values by individual
clonal cell line on indicated day of differentiation.
Horizontal lines show average values for all tested
clonal cell lines (n = 24).
(G) Kinetic analysis of mesenchymal lineage-
specific gene expression in polyclonal MSC lines
differentiated during 24 days under chondrogenic,
osteogenic, and adipogenic conditions, as
determined by quantitative RT-PCR. Average
expression normalized to RPL13A. Error bars
represent standard deviation of three independent
experiments.
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Identification of MesenchymoangioblastMesenchymoangioblasts Originate from Population
of Mesodermal Cells Identified by Expression of Apelin
Receptor
Demonstration of endothelial potential of MS colonies strongly
indicates the mesodermal origin of MS-CFCs. However, neural
crest origin of these cells could not be completely excluded,
because the potential of neural crest cells to form corneal endo-
thelium is recognized (Noden, 1978). To more precisely define
the source of mesenchymoangioblasts, we decided to identify
a cell population enriched in MS-CFCs. Although VEGFR2
(Flk1 or KDR) and PDGFRa in mouse are well-defined markers
of mesoderm with the potential to generate hematovascular
and mural cells (Orr-Urtreger et al., 1992; Sakurai et al., 2006;
Yamaguchi et al., 1993; Yamashita et al., 2000), we noticed
that both of them were expressed weakly following 2–3 days of
hESC differentiation in OP9 (Figure 6A), complicating isolation
of discrete populations by sorting. Moreover, the KDR expres-
sion in undifferentiated hESCs limits the utility of this marker
for isolation of early-differentiated cell population (VodyanikCell Stem Cell 7, 718–729,et al., 2005; Yang et al., 2008). During
analysis of the transcriptional profile of
differentiated hESCs in OP9 coculture,
we found that expression of apelin
receptor (APLNR, also known as angio-
tensin receptor like-1) was strongly
induced and upregulated on days 2–3 of
differentiation, concurrently with meso-
dermal commitment and colony-forming
activity. Because previous studies
showed APLNR expression in lateral
plate mesoderm and its precursors in
Xenopus and zebrafish embryo atgastrula stage (Devic et al., 1996; Zeng et al., 2007) and in prim-
itive streak and adjacent embryonic and extraembryonic
mesoderm in mouse embryo (D’Aniello et al., 2009), we studied
APLNR expression following hESC differentiation by flow cytom-
etry. Unlike KDR, undifferentiated hESCs were homogeneously
APLNR. On day 2 of coculture, 15%–20% of differentiated
hESCs became APLNR+. The proportion of positive cells
increased to 60%–70% on day 3 and gradually decreased in
the following days (Figure 6A). In contrast to the low initial
expression of PDGFRa and KDR, the first positive cells
expressed APLNR in high density, thus allowing for a clean
separation of negative and positive populations. Costaining
with anti-T and anti-FOXA2 antibodies revealed that APLNR+
cells were T+FOXA2 mesodermal precursors (Figure 6A).
Further proof that APLNR+ cells represent mesoderm was ob-
tained by differentiating hESCs in the presence of inhibitors of
WNT and TGF-b signaling and mesoderm induction (Gadue
et al., 2006). These experiments demonstrated almost an entire
abrogation of the APLNR+ population in OP9 cocultureDecember 3, 2010 ª2010 Elsevier Inc. 723
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Figure 6. Identification of APLNR as a Marker of Mesoderm Generated from hESCs in Coculture with OP9
(A) Characterization of H1 hESC-derived APLNR+ cells by flow cytometry.
(B) Effect of WNT (DKK-1, dickkopf homolog 1; 150 mg/ml) and TGF-b1 (SB431542; 5 mg/ml) signaling inhibitors on generation of APLNR+ cells. Error bars repre-
sent standard deviation of four independent experiments.
(C) Enrichment of mesodermal transcripts in APLNR+ cells isolated on day 3 of differentiation.
(D) Frequency of MS- and BL-CFCs in APLNR+ and APLNR cell fractions isolated at days 2, 2.5, and 3 of hESC/OP9 coculture. Error bars represent standard
deviation of three independent experiments. See also Figure S5.
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Identification of Mesenchymoangioblast(Figure 6B). The molecular profiling analysis shown in Figure 6C
and Figure 7 demonstrated that transcripts associated with
neural crest and neuroectoderm (POU4F1, SOX1, SOX10,
SOX3) were not found in APLNR+ cells. Genes indicative of prim-
itive streak cells/mesendoderm (MIXL1, T, EOMES) were all
expressed but not enriched in APLNR+ cells, consistent with
their advanced lineage commitment. As expected, APLNR+ cells
were enriched in TCF21 mesoderm-specific transcripts,
whereas transcripts marking panendoderm (FOXA2, APOA1),
definitive (FOXA1, TMPRSS2), and visceral (TTR, AFP) endo-
derm were found in APLNR cells. Interestingly, APLNR+ cells
expressed the FOXF1, IRX3, BMP4, WNT5A, HAND1, and
HAND2 genes, representative of lateral plate/extarembryonic
mesoderm, but not the markers of paraxial/myogenic (MEOX1,
TCF15, PAX3, PAX7) and intermediate (PAX2, PAX8) mesoderm
in the embryo. These data indicate that, rather than being a total
population of cells committed to mesendodermal development,
APLNR+ cells represent a mesoderm, or likely a subpopulation
reminiscent of lateral plate/extraembryonic mesoderm.
To determine the origin of MS- and BL-CFCs, we fractionated
differentiated hESCs into APLNR+ and APLNR cells and
assayed for FGF2-dependent colony-forming potential. As
shown in Figure 6D, selection of APLNR+ cells resulted in almost724 Cell Stem Cell 7, 718–729, December 3, 2010 ª2010 Elsevier Incthe entire depletion of MS-CFCs and BL-CFCs in APLNR frac-
tion. However, the enrichment in MS-CFCs in APLNR+ fraction
was less than expected. To find out whether poor enrichment
could be caused by the inhibition of MS-CFCs by antibody
binding to APLNR through modulation of apelin signaling, we
tested the effect of adding anti-APLNR antibody and APLNR
ligand apelin-12 to clonogenic cultures of day 2 unseparated
hESCs. As shown in Figure S5A, apelin-12 inhibited MS colony
formation, indicating that signaling through APLNR has a nega-
tive effect on MS-CFCs. Because a similar inhibitory effect was
observed in cultures containing antibody, we concluded that
anti-APLNR monoclonal antibody used in this study possesses
agonistic properties, which can explain limitedMS-CFCs enrich-
ment in APLNR+ fraction following magnetic separation. Never-
theless, segregation of MS- and BL-CFCs almost exclusively
to APLNR+ fraction additionally confirmed the mesodermal
origin of mesenchymal precursors. Because no expression of
neuroepthelial and neural crest markers, including SOX1, was
detected in APLNR+ cells, MS colonies, or MSCs (Figure 7B),
neural crest origin of MSCs in our culture systemwas completely
excluded.
Flow cytometric analysis (Figure S5B) and molecular profiling
data (Figure S1) demonstrated that mesenchymoangioblasts.
AC
B
Figure 7. Gene Expression Profiling of APLNR+ and APLNR– Cells, Cores, MS and BL Colonies, and MSC Lines Obtained from H1 hESCs
Differentiated for 2 or 3 Days in Coculture with OP9
(A) Shown are heat maps for selected sets of genes defining indicated germ layers and their subpopulations/derivatives. Cores were collected on day 3 (D3) of
clonogenic cultures, and fully developed colonies were collected on day 12 of clonogenic cultures. EMT denotes epithelial-mesenchymal transition; VSMC
denotes vascular smooth muscle cells; p1 and p5 denote passage 1 and passage 5, respectively.
(B) Lack ofSOX1 neuroepitheliummarker expression throughout all stages of differentiation. H1 embryonic bodies differentiated for 14 dayswere used as positive
control.
(C) Quantitative RT-PCR analysis of representative transcripts in indicated cell subsets. Scale bars represent gene expression in pooled samples from three
experiments normalized to RPL13.
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Identification of Mesenchymoangioblastdevelop within 48 hr of differentiation prior to the expression of
CD73 and CD105 MSC markers and upregulation of MSC-
related genes, i.e., onset of mesenchymogenesis. Although
MS-CFCs arise from a APLNR+mesodermwith silent endothelial
genes, their specification toward MSCs in colony-forming
cultures proceeds through the core stage at which cells acquire
angioblastic gene expression profile (Figures 7A and 7C) and
endothelial differentiation potential, which is mostly detectable
during the early stages of colony formation (Figure S4B). This
activation of an endothelial program was evident during the
core formation of both MS and BL colonies, although additional
divergent activation of mesenchymal versus hematopoietic
genes was obvious. Maturation of MS colonies was associated
with progressive loss of endothelial and gain of mesenchymal
potential, indicating that specification of APLNR+ cells toward
mesenchymal cells in clonogenic cultures proceeds through
formation of angiogenic core, followed by its progressive trans-
formation into tripotential mesenchymal cells.DISCUSSION
In the present study, we demonstrate for the first time that
mesoderm-derived MSCs originate from precursors with angio-
genic potential, called mesenchymomagioblasts, which we
identified as MS-CFCs with the potential to differentiate into
both MSCs and endothelial cells. In embryo, early angiogenic
precursors are scattered throughout the mesoderm, and some
of them possess strong migratory activity (Cleaver and Krieg,
1998; Noden, 1990; Pardanaud et al., 1996). Endothelial precur-
sors originating in paraxial mesoderm vascularize predominantly
kidney and body wall, whereas endothelial precursors of lateral
plate mesoderm origin vascularize visceral organs and
contribute to aortic floor and intra-aortic hematopoietic cell
clusters (Pardanaud et al., 1996). Early angiogenic precursors
seem to possess a broad differentiation potential, including
blood, cartilage, bone, smooth, skeletal, and cardiac muscle
(Minasi et al., 2002). It is well documented that distinct popula-
tions of endothelial cells within the floor of the dorsal aorta give
rise to hematopoietic stem cells and that bipotential precursors
with endothelial and hematopoietic differentiation potential are
identified in ESC cultures (Bertrand et al., 2010; Boisset et al.,
2010; Choi et al., 1998; Kissa and Herbomel, 2010; Nishikawa
et al., 1998; Taoudi and Medvinsky, 2007; Zovein et al., 2008).
However, association between endothelial precursors and
MSCs is not well established, although cells with endothelial
and mural cell differentiation potential have been demonstrated
in Flk1+ cells generated from mouse ESCs (Yamashita et al.,
2000). In our studies, the identification of a clonal mesodermal
precursor mesenchymoangioblast giving rise to endothelial cells
and MSCs with robust expansion and trilineage (chondro-,
osteo-, and adipogenesis) differentiation potential strongly
indicates the branching off of the MSCs from precursors with
primary endothelial characteristics. The development of MSCs
through the endothelial pathway could be a potentially distinctive
feature of mesoderm-derived MSCs, because neural crest-
derived MSCs initially arise from neuroepithelium (Takashima
et al., 2007). Interestingly, neural crest and angioblasts are two
major types of cells that migrate extensively during embryonic726 Cell Stem Cell 7, 718–729, December 3, 2010 ª2010 Elsevier Incdevelopment (Evans and Noden, 2006). These properties could
be important for establishing MSC network within the tissues.
In contrast to the previously described meso-angioblast,
a mesodermal progenitor with angiogenic characteristics and
broad differentiation potential (Minasi et al., 2002), the mesen-
chymoangioblast identified in our studies demonstrates a more
narrow differentiation capability (MSCs and endothelium).
Because mesenchymogenic MS-CFCs and hemogenic
BL-CFCs arose in continuity and show more limited differentia-
tion potential, these cells could represent precursors down-
stream of common mesodermal precursor, defining the stage
when cells with multipotent mesodermal potential diversify into
angiogenic subsets with more restricted mesenchymal or blood
differentiation potential (see graphical abstract available online).
Flk1 (VEGFR2 or KDR) is a well-established marker of meso-
derm and angiogenic precursors in mouse embryo and differen-
tiated ESC cultures (Orr-Urtreger et al., 1992; Sakurai et al.,
2006; Yamaguchi et al., 1993; Yamashita et al., 2000). However,
KDR is expressed in undifferentiated hESCs (Vodyanik et al.,
2005; Yang et al., 2008), and its expression at early stages of
differentiation ismostly weak (see Figure 6A). This limits the utility
of KDR for isolation of discretely defined negative and positive
populations. Our data indicate that APLNR could be a good
alternative to KDR marker for isolation of early mesoderm-
committed population from hESCs in OP9 coculture because
of its absence in undifferentiated hESCs and much brighter
expression following early differentiation. APLNR (also known
as angiotensin type I-like receptor, AGTRL1, or APJ) is
a G-coupled protein receptor activated by its ligand apelin,
a peptide originating frompreapelin (Habata et al., 1999). Studies
in Xenopus and zebrafish indicated a critical role of APLNR-
mediated signaling in normal vascular and cardiac development
and migration of myocardial progenitors (Inui et al., 2006; Scott
et al., 2007). At gastrula stage in Xenopus, expression of apelin
receptor (X-msr) was first detected in the prospective lateral
plate mesoderm cells and later became restricted to lateral plate
mesoderm (Devic et al., 1996). During gastrulation in zebrafish,
APLNR is expressed in adaxial, intermediate, and lateral plate
mesoderm, including anterior lateral plate mesoderm, where
cardiac precursors develop (Zeng et al., 2007). In E8 mouse
embryos, APLNR is detected in primitive streak, adjacent meso-
derm, and extraembryonic mesoderm (D’Aniello et al., 2009).
Molecular profiling studies presented here demonstrate that
OP9 induces selective commitment of hESCs to mesoderm
and endoderm with predominant expansion of lateral plate/
extraembryonic mesoderm and their derivates. Selection of
APLNR+ population enriches cells with a lateral plate/extraem-
bryonic mesoderm gene expression profile. Although the full
differentiation potential of APLNR+ cells remains to be deter-
mined, our studies indicate that these cells can generate at least
MSCs, endothelial cells, and blood cells, thus confirming the
identity of APLNR+ population as lateral plate/extraembryonic
mesoderm. Importantly, APLNR expression was detected
before differentiated hESCs acquire expression CD73 and
CD105 MSC markers, thus making it possible to separate MSC
precursors from already-established MSCs.
In conclusion, the identification of mesenchymoangioblast
as a precursor for mesenchymal and endothelial cells and
APLNR+ as a marker of mesodermal population with.
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Identification of Mesenchymoangioblastangiohematopoietic and MSC potential offers a novel opportu-
nity to investigate the cellular and molecular pathways for the
development of mesodermal lineage cells. In addition, access
to clonal MSC populations with a well-defined origin, differentia-
tion, and robust expansion potential could provide a unique cell
source for tissue engineering and MSC-based medical
therapies.
EXPERIMENTAL PROCEDURES
Maintenance of Human ESCs and iPSCs
Human ESC (H1, H13, H9) (Thomson et al., 1998) lines were obtained from
WiCell Research Institute. iPSCs (iPS(IMR)-90-1 and iPS(FSK)-1) were gener-
ated by reprogramming fetal and neonatal fibroblasts using lentiviral vectors
(Yu et al., 2007). Transgene-free iPS-1 (19-9-7T) and iPS-5 (4-3-7T) were
produced by episomal vectors (Yu et al., 2009). HES2.R26-RFP cell line (Irion
et al., 2007) was provided by Gordon Keller (Mount Sinai School of Medicine).
All hES and iPSC lines were maintained in undifferentiated state on irradiated
mouse embryonic fibroblasts as described (Amit et al., 2000; Yu et al., 2007).
hESC and iPSC Differentiation in OP9 Coculture
Mouse OP9 bone marrow stromal cell line was provided by Toru Nakano
(OsakaUniversity). hESCs and iPSCswere induced to differentiate in coculture
with OP9 stromal cells and were depleted of OP9 cells using anti-mouse CD29
antibodies (AbD Serotec) as described (Vodyanik et al., 2005; Vodyanik and
Slukvin, 2007).
Colony-Forming Culture for Mesodermal Precursors
Schematic diagram of the protocol used for generation of MS colonies and
MSC lines is depicted in Figure S6. Single-cell suspension of hESC- and
iPSC-derived cells was prepared at 0.5–2 3 104 cells/ml in the semisolid
colony-forming serum-free medium (CF-SFM) containing 40% ES-Cult
M3120 methylcellulose (2.5% solution in Iscove’s modified Dulbecco’s
medium; Stem Cell Technologies), 25% StemSpan serum-free expansion
medium (SFEM; Stem Cell Technologies), 25% human endothelial serum-
free medium (ESFM; Invitrogen), 10% BIT 9500 supplement (Stem Cell Tech-
nologies), GlutaMAX (1/100 dilution; Invitrogen), Ex-Cyte supplement (1/1000
dilution; Millipore), 100 mM monothioglycerol (MTG), 50 mg/ml ascorbic acid,
and 20 ng/ml basic fibroblast growth factor (FGF2). Where indicated, human
PDGF-BB (10 ng/ml), VEGF (20 ng/ml), stem cell factor (SCF; 50 ng/ml),
epidermal growth factor (EGF; 20 ng/ml), insulin-like growth factor 1 (IGF1;
50 ng/ml), hepatocyte growth factor (HGF; 20 ng/ml), activin A (1 ng/ml), trans-
forming growth factor b1 (TGF-b1; 1 ng/ml), bone-morphogenic protein-4
(BMP-4; 5 ng/ml), apelin-12 (100 ng/ml; Phoenix Pharmaceuticals), or anti-
APLNR monoclonal antibody (5 mg/ml; R&D Systems) were added to cultures.
All cytokines were purchased from Peprotech. MS and BL colonies were
scored on 12th day of culture. Individual MS colonies were picked from culture
under inverted microscope. For bulk collection of MS colonies (>100 mm in
diameter), day 12 colony-forming cultures were diluted 1/5 in Dulbecco’s
modified Eagle’s medium/F12 medium and filtered through 100 mm cell
strainers (BD Biosciences). Cores from day 3 colony-forming cultures were
purified in a similar manner using 30 mm cell strainers.
Colony-Derived MSC Lines
Fibronectin plus collagen-coated plastic was prepared by incubation of tissue
culture-grade plastic (BD Bioscience) with human fibronectin (5 mg/ml; Invitro-
gen) and human collagen I (10 mg/ml; Stem Cell Technologies) solutions in
phosphate-buffered saline. Individual or multiple MS colonies collected by
filtration (>100 colonies per culture) were plated on the fibronectin- and
collagen-coated plastic in mesenchymal serum-free expansion medium
(M-SFEM) containing 50% StemLine II serum-free HSC expansion medium
(HSFEM; Sigma), 50% ESFM, GlutaMAX (1/100 dilution), Ex-Cyte supplement
(1/2000 dilution), 100 mMMTG, and 10 ng/ml FGF2. After 3 days, the attached
colonies were dissociated by StemPro Accutase solution (Invitrogen) and
plated on the fibronectin- and collagen-coated dishes in M-SFEM medium.
Colony-derived MSC lines established either from individual (clonal lines) or
multiple (polyclonal lines) colonies were routinely maintained by 3 day subcul-Celture on fibronectin- and collagen-coated 10 cm dishes using StemPro Accu-
tase detachment solution and M-SFEM. The first confluent culture was de-
noted as passage 1.
Analysis of Angiohematopoietic Potential of MS and BL Colonies
and MSC Lines
MS and BL colonies or MSC lines were cocultured with OP9 in aMEM supple-
mented with 10% fetal bovine serum and cytokines SCF (50 ng/ml), TPO
(50 ng/ml), IL-3 (10 ng/ml), and IL-6 (20 ng/ml). After 4 days of culture, cells
were harvested and analyzed by flow cytometry or stained in situ with rabbit
anti-human CD144 (VE-cadherin; 1 mg/ml; eBioscience) in combination with
mouse anti-human CD43 (0.5 mg/ml; BD Bioscience), mouse anti-human
Calponin (0.5 mg/ml; Thermo Fisher Scientific), anti-human nuclei (Millipore;
clone 235-1; 1/1000 dilution), or anti-human OB-cadherin (Invitrogen) primary
antibodies, followed by a mix of secondary cross-absorbed donkey anti-
mouse IgG-DyLight 594 and donkey anti-rabbit IgG-DyLight-488 (both at
2 mg/ml; Jackson ImmunoResearch Laboratories) antibodies. For vascular
tube formation, MS colonies were collected at day 6 of clonogenic culture,
transferred onto growth factor-reduced Matrigel (BD Biosciences), and
cultured in EGM-2 endothelial cell growth medium (Lonza) at 37C.
Isolation of APLNR+ Cells
To detect and isolate APLNR+ cells, we conjugated anti-human APLNR (APJ,
AGTRL1) mAb (clone 72133, R&D Systems) with APC by Lightning-Link-APC
kit (Innova Biosciences). Isolation of APLNR+ cells was performed using
MACS and anti-APC magnetic beads (Miltenyi Biotec). APLNR+ cells were
purified using LS+ positive selection columns. Negative cell fraction from
LS+ column was additionally passed through high-retention LD depletion
column to obtain fraction of APLNR cells. The purity of APLNR+ cells was
higher than 95%, as verified by flow cytometry. APLNR cells contained
<1% APLNR+ cells. All antibodies and primers used in this study are listed in
Tables S1 and S2.
Statistical Tests
The significance of differences between the mean values was determined by
paired Student’s t test.
SUPPLEMENTAL INFORMATION
The Supplemental Information includes Supplemental Experimental Proce-
dures, six supplemental figures, two tables, and three movies and can be
found with this article online at doi:10.1016/j.stem.2010.11.011.
ACKNOWLEDGMENTS
We thank Toru Nakano for providing OP9 cells, Dietmar Vestweber for
providing endomucin antibodies, Gordon Keller for providing HES2.R26tdRFP
hESC line, Mitchell Probasco for cell sorting, Clay Glennon for time-lapse
photography, and Joan Larson and Krista Eastman for editorial assistance.
This work was supported by funds from the National Institutes of Health
(R01 HL081962, P01 GM081629, and P51 RR000167) and the Charlotte Geyer
Foundation. J.A.T. owns stock, serves on theBoard of Directors, and serves as
Chief Scientific Officer of Cellular Dynamics International. J.A.T. also serves as
Scientific Director of the WiCell Research Institute. I.I.S. owns stock and is the
scientific founder of Cellular Dynamics International.
Received: May 19, 2010
Revised: August 5, 2010
Accepted: September 13, 2010
Published: December 2, 2010
REFERENCES
Amit, M., Carpenter, M.K., Inokuma, M.S., Chiu, C.P., Harris, C.P., Waknitz,
M.A., Itskovitz-Eldor, J., and Thomson, J.A. (2000). Clonally derived human
embryonic stem cell lines maintain pluripotency and proliferative potential
for prolonged periods of culture. Dev. Biol. 227, 271–278.l Stem Cell 7, 718–729, December 3, 2010 ª2010 Elsevier Inc. 727
Cell Stem Cell
Identification of MesenchymoangioblastBarberi, T., Willis, L.M., Socci, N.D., and Studer, L. (2005). Derivation of multi-
potent mesenchymal precursors from human embryonic stem cells. PLoS
Med. 2, e161.
Bertrand, J.Y., Chi, N.C., Santoso, B., Teng, S., Stainier, D.Y., and Traver, D.
(2010). Haematopoietic stem cells derive directly from aortic endothelium
during development. Nature 464, 108–111.
Bianco, P., Robey, P.G., and Simmons, P.J. (2008). Mesenchymal stem cells:
Revisiting history, concepts, and assays. Cell Stem Cell 2, 313–319.
Blazsek, I., Chagraoui, J., and Pe´ault, B. (2000). Ontogenic emergence of the
hematon, a morphogenetic stromal unit that supports multipotential hemato-
poietic progenitors in mouse bone marrow. Blood 96, 3763–3771.
Boisset, J.C., van Cappellen, W., Andrieu-Soler, C., Galjart, N., Dzierzak, E.,
and Robin, C. (2010). In vivo imaging of haematopoietic cells emerging from
the mouse aortic endothelium. Nature 464, 116–120.
Boyd, N.L., Robbins, K.R., Dhara, S.K., West, F.D., and Stice, S.L. (2009).
Human embryonic stem cell-derived mesoderm-like epithelium transitions to
mesenchymal progenitor cells. Tissue Eng. Part A 15, 1897–1907.
Choi, K., Kennedy, M., Kazarov, A., Papadimitriou, J.C., and Keller, G. (1998).
A common precursor for hematopoietic and endothelial cells. Development
125, 725–732.
Ciruna, B., and Rossant, J. (2001). FGF signaling regulates mesoderm cell fate
specification and morphogenetic movement at the primitive streak. Dev. Cell
1, 37–49.
Cleaver, O., and Krieg, P.A. (1998). VEGF mediates angioblast migration
during development of the dorsal aorta in Xenopus. Development 125,
3905–3914.
Crisan, M., Yap, S., Casteilla, L., Chen, C.W., Corselli, M., Park, T.S., Andriolo,
G., Sun, B., Zheng, B., Zhang, L., et al. (2008). A perivascular origin for mesen-
chymal stem cells in multiple human organs. Cell Stem Cell 3, 301–313.
D’Aniello, C., Lonardo, E., Iaconis, S., Guardiola, O., Liguoro, A.M., Liguori,
G.L., Autiero, M., Carmeliet, P., and Minchiotti, G. (2009). G protein-coupled
receptor APJ and its ligand apelin act downstream of Cripto to specify embry-
onic stem cells toward the cardiac lineage through extracellular signal-regu-
lated kinase/p70S6 kinase signaling pathway. Circ. Res. 105, 231–238.
D’Souza, S.L., Elefanty, A.G., and Keller, G. (2005). SCL/Tal-1 is essential for
hematopoietic commitment of the hemangioblast but not for its development.
Blood 105, 3862–3870.
Delorme, B., Chateauvieux, S., and Charbord, P. (2006). The concept of
mesenchymal stem cells. Regen. Med. 1, 497–509.
Dennis, J.E., and Charbord, P. (2002). Origin and differentiation of human and
murine stroma. Stem Cells 20, 205–214.
Devic, E., Paquereau, L., Vernier, P., Knibiehler, B., and Audigier, Y. (1996).
Expression of a new G protein-coupled receptor X-msr is associated with an
endothelial lineage in Xenopus laevis. Mech. Dev. 59, 129–140.
Evans, D.J., and Noden, D.M. (2006). Spatial relations between avian cranio-
facial neural crest and paraxial mesoderm cells. Dev. Dyn. 235, 1310–1325.
Friedenstein, A.J., Chailakhyan, R.K., Latsinik, N.V., Panasyuk, A.F., and
Keiliss-Borok, I.V. (1974). Stromal cells responsible for transferring the micro-
environment of the hemopoietic tissues. Cloning in vitro and retransplantation
in vivo. Transplantation 17, 331–340.
Gadue, P., Huber, T.L., Nostro, M.C., Kattman, S., and Keller, G.M. (2005).
Germ layer induction from embryonic stem cells. Exp. Hematol. 33, 955–964.
Gadue, P., Huber, T.L., Paddison, P.J., and Keller, G.M. (2006). Wnt and TGF-
beta signaling are required for the induction of an in vitro model of primitive
streak formation using embryonic stem cells. Proc. Natl. Acad. Sci. USA
103, 16806–16811.
Habata, Y., Fujii, R., Hosoya, M., Fukusumi, S., Kawamata, Y., Hinuma, S.,
Kitada, C., Nishizawa, N., Murosaki, S., Kurokawa, T., et al. (1999). Apelin,
the natural ligand of the orphan receptor APJ, is abundantly secreted in the
colostrum. Biochim. Biophys. Acta 1452, 25–35.
Inui, M., Fukui, A., Ito, Y., and Asashima, M. (2006). Xapelin and Xmsr are
required for cardiovascular development in Xenopus laevis. Dev. Biol. 298,
188–200.728 Cell Stem Cell 7, 718–729, December 3, 2010 ª2010 Elsevier IncIrion, S., Luche, H., Gadue, P., Fehling, H.J., Kennedy, M., and Keller, G.
(2007). Identification and targeting of the ROSA26 locus in human embryonic
stem cells. Nat. Biotechnol. 25, 1477–1482.
Karlsson, C., Emanuelsson, K., Wessberg, F., Kajic, K., Axell, M.Z., Eriksson,
P.S., Lindahl, A., Hyllner, J., and Strehl, R. (2009). Human embryonic stem cell-
derived mesenchymal progenitors-Potential in regenerative medicine. Stem
Cell Res.. Published online May 19, 2009.
Kennedy, M., Firpo, M., Choi, K., Wall, C., Robertson, S., Kabrun, N., and
Keller, G. (1997). A common precursor for primitive erythropoiesis and defini-
tive haematopoiesis. Nature 386, 488–493.
Kennedy, M., D’Souza, S.L., Lynch-Kattman, M., Schwantz, S., and Keller, G.
(2007). Development of the hemangioblast defines the onset of hematopoiesis
in human ES cell differentiation cultures. Blood 109, 2679–2687.
Kissa, K., and Herbomel, P. (2010). Blood stem cells emerge from aortic endo-
thelium by a novel type of cell transition. Nature 464, 112–115.
Lee, G., Kim, H., Elkabetz, Y., Al Shamy, G., Panagiotakos, G., Barberi, T.,
Tabar, V., and Studer, L. (2007). Isolation and directed differentiation of neural
crest stem cells derived from human embryonic stem cells. Nat. Biotechnol.
25, 1468–1475.
Lian, Q., Lye, E., Suan Yeo, K., Khia Way Tan, E., Salto-Tellez, M., Liu, T.M.,
Palanisamy, N., El Oakley, R.M., Lee, E.H., Lim, B., and Lim, S.K. (2007).
Derivation of clinically compliant MSCs from CD105+, CD24- differentiated
human ESCs. Stem Cells 25, 425–436.
Lian, Q., Zhang, Y., Zhang, J., Zhang, H.K., Wu, X., Zhang, Y., Lam, F.F., Kang,
S., Xia, J.C., Lai, W.H., et al. (2010). Functional mesenchymal stem cells
derived from human induced pluripotent stem cells attenuate limb ischemia
in mice. Circulation 121, 1113–1123.
Mendes, S.C., Robin, C., and Dzierzak, E. (2005). Mesenchymal progenitor
cells localize within hematopoietic sites throughout ontogeny. Development
132, 1127–1136.
Minasi, M.G., Riminucci, M., De Angelis, L., Borello, U., Berarducci, B.,
Innocenzi, A., Caprioli, A., Sirabella, D., Baiocchi, M., De Maria, R., et al.
(2002). The meso-angioblast: A multipotent, self-renewing cell that originates
from the dorsal aorta and differentiates into most mesodermal tissues.
Development 129, 2773–2783.
Morikawa, S., Mabuchi, Y., Niibe, K., Suzuki, S., Nagoshi, N., Sunabori, T.,
Shimmura, S., Nagai, Y., Nakagawa, T., Okano, H., and Matsuzaki, Y.
(2009). Development of mesenchymal stem cells partially originate from the
neural crest. Biochem. Biophys. Res. Commun. 379, 1114–1119.
Muguruma, Y., Yahata, T., Miyatake, H., Sato, T., Uno, T., Itoh, J., Kato, S., Ito,
M., Hotta, T., and Ando, K. (2006). Reconstitution of the functional human
hematopoietic microenvironment derived from human mesenchymal stem
cells in the murine bone marrow compartment. Blood 107, 1878–1887.
Nakano, T., Kodama, H., and Honjo, T. (1994). Generation of lymphohemato-
poietic cells from embryonic stem cells in culture. Science 265, 1098–1101.
Nishikawa, S.I., Nishikawa, S., Hirashima,M., Matsuyoshi, N., and Kodama, H.
(1998). Progressive lineage analysis by cell sorting and culture identifies
FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic
lineages. Development 125, 1747–1757.
Noden, D.M. (1978). The control of avian cephalic neural crest cytodifferentia-
tion. I. Skeletal and connective tissues. Dev. Biol. 67, 296–312.
Noden, D.M. (1990). Origins and assembly of avian embryonic blood vessels.
Ann. N Y Acad. Sci. 588, 236–249.
Olivier, E.N., Rybicki, A.C., and Bouhassira, E.E. (2006). Differentiation of
human embryonic stem cells into bipotent mesenchymal stem cells. Stem
Cells 24, 1914–1922.
Orr-Urtreger, A., Bedford, M.T., Do, M.S., Eisenbach, L., and Lonai, P. (1992).
Developmental expression of the alpha receptor for platelet-derived growth
factor, which is deleted in the embryonic lethal Patch mutation.
Development 115, 289–303.
Pardanaud, L., Luton, D., Prigent, M., Bourcheix, L.M., Catala, M., and
Dieterlen-Lievre, F. (1996). Two distinct endothelial lineages in ontogeny,
one of them related to hemopoiesis. Development 122, 1363–1371..
Cell Stem Cell
Identification of MesenchymoangioblastProckop, D.J. (1997). Marrow stromal cells as stem cells for nonhematopoietic
tissues. Science 276, 71–74.
Sacchetti, B., Funari, A., Michienzi, S., Di Cesare, S., Piersanti, S., Saggio, I.,
Tagliafico, E., Ferrari, S., Robey, P.G., Riminucci, M., and Bianco, P. (2007).
Self-renewing osteoprogenitors in bone marrow sinusoids can organize
a hematopoietic microenvironment. Cell 131, 324–336.
Sakurai, H., Era, T., Jakt, L.M., Okada, M., Nakai, S., Nishikawa, S., and
Nishikawa, S. (2006). In vitro modeling of paraxial and lateral mesoderm differ-
entiation reveals early reversibility. Stem Cells 24, 575–586.
Schroeder, T., Fraser, S.T., Ogawa, M., Nishikawa, S., Oka, C., Bornkamm,
G.W., Nishikawa, S., Honjo, T., and Just, U. (2003). Recombination signal
sequence-binding protein Jkappa alters mesodermal cell fate decisions by
suppressing cardiomyogenesis. Proc. Natl. Acad. Sci. USA 100, 4018–4023.
Scott, I.C., Masri, B., D’Amico, L.A., Jin, S.W., Jungblut, B., Wehman, A.M.,
Baier, H., Audigier, Y., and Stainier, D.Y. (2007). The g protein-coupled
receptor agtrl1b regulates early development of myocardial progenitors.
Dev. Cell 12, 403–413.
Takashima, Y., Era, T., Nakao, K., Kondo, S., Kasuga, M., Smith, A.G., and
Nishikawa, S. (2007). Neuroepithelial cells supply an initial transient wave of
MSC differentiation. Cell 129, 1377–1388.
Taoudi, S., and Medvinsky, A. (2007). Functional identification of the hemato-
poietic stem cell niche in the ventral domain of the embryonic dorsal aorta.
Proc. Natl. Acad. Sci. USA 104, 9399–9403.
Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J.,
Marshall, V.S., and Jones, J.M. (1998). Embryonic stem cell lines derived from
human blastocysts. Science 282, 1145–1147.
Trentin, A., Glavieux-Pardanaud, C., Le Douarin, N.M., and Dupin, E. (2004).
Self-renewal capacity is a widespread property of various types of neural crest
precursor cells. Proc. Natl. Acad. Sci. USA 101, 4495–4500.
Trivedi, P., and Hematti, P. (2008). Derivation and immunological characteriza-
tion of mesenchymal stromal cells from human embryonic stem cells. Exp.
Hematol. 36, 350–359.
Tsutsumi, S., Shimazu, A., Miyazaki, K., Pan, H., Koike, C., Yoshida, E.,
Takagishi, K., and Kato, Y. (2001). Retention of multilineage differentiation
potential of mesenchymal cells during proliferation in response to FGF.
Biochem. Biophys. Res. Commun. 288, 413–419.CelVodyanik, M.A., and Slukvin, I.I. (2007). Hematoendothelial differentiation of
human embryonic stem cells. Curr. Protoc. Cell Biol. 27, 559–567.
Vodyanik, M.A., Bork, J.A., Thomson, J.A., and Slukvin, I.I. (2005). Human
embryonic stem cell-derived CD34+ cells: Efficient production in the coculture
with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood
105, 617–626.
Vodyanik, M.A., Thomson, J.A., and Slukvin, I.I. (2006). Leukosialin (CD43)
defines hematopoietic progenitors in human embryonic stem cell differentia-
tion cultures. Blood 108, 2095–2105.
Yamaguchi, T.P., Dumont, D.J., Conlon, R.A., Breitman, M.L., and Rossant, J.
(1993). flk-1, an flt-related receptor tyrosine kinase is an early marker for endo-
thelial cell precursors. Development 118, 489–498.
Yamashita, J., Itoh, H., Hirashima, M., Ogawa, M., Nishikawa, S., Yurugi, T.,
Naito, M., Nakao, K., and Nishikawa, S. (2000). Flk1-positive cells derived
from embryonic stem cells serve as vascular progenitors. Nature 408, 92–96.
Yang, L., Soonpaa, M.H., Adler, E.D., Roepke, T.K., Kattman, S.J., Kennedy,
M., Henckaerts, E., Bonham, K., Abbott, G.W., Linden, R.M., et al. (2008).
Human cardiovascular progenitor cells develop from a KDR+ embryonic-
stem-cell-derived population. Nature 453, 524–528.
Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L.,
Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., et al. (2007). Induced
pluripotent stem cell lines derived from human somatic cells. Science 318,
1917–1920.
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I.I., and Thomson,
J.A. (2009). Human induced pluripotent stem cells free of vector and transgene
sequences. Science 324, 797–801.
Zambidis, E.T., Peault, B., Park, T.S., Bunz, F., and Civin, C.I. (2005).
Hematopoietic differentiation of human embryonic stem cells progresses
through sequential hematoendothelial, primitive, and definitive stages resem-
bling human yolk sac development. Blood 106, 860–870.
Zeng, X.X., Wilm, T.P., Sepich, D.S., and Solnica-Krezel, L. (2007). Apelin and
its receptor control heart field formation during zebrafish gastrulation. Dev.
Cell 12, 391–402.
Zovein, A.C., Hofmann, J.J., Lynch, M., French, W.J., Turlo, K.A., Yang, Y.,
Becker, M.S., Zanetta, L., Dejana, E., Gasson, J.C., et al. (2008). Fate tracing
reveals the endothelial origin of hematopoietic stem cells. Cell Stem Cell 3,
625–636.l Stem Cell 7, 718–729, December 3, 2010 ª2010 Elsevier Inc. 729
